Compound 1842
Identifiers
- Canonical SMILES:
CN1CCC2=C(Cc3nc([nH]c(=O)c23)-c2ccc(O)cc2)C1
- IUPAC name:
5-(4-hydroxyphenyl)-11-methyl-4,6,11-triazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5-trien-3-one
- InChi:
InChI=1S/C17H17N3O2/c1-20-7-6-13-11(9-20)8-14-15(13)17(22)19-16(18-14)10-2-4-12(21)5-3-10/h2-5,21H,6-9H2,1H3,(H,18,19,22)
- InChiKey:
UNDJGGZQEYCWJS-UHFFFAOYSA-N
External links
![]() 168317742 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.14 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 295.13 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | -0.84 | |||
TPSA | 67.74 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.7b00275 | 9e | BRD4 O60885 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.14 | |
10.1021/acs.jmedchem.7b00275 | 9e | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MCF-7 | MCF7 mammary carcinoma cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.26 |
10.1021/acs.jmedchem.7b00275 | 9e | BRD4 O60885 |
H4 P62805 |
Cellular assay | Anti-proliferative MDA-MB-231 | MDA-MB-231 breast | pIC50 (half maximal inhibitory concentration, -log10) | 5.08 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4676 | 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone | DB03072 | |
0.3745 | Risperidone | DB00734 | |
0.3692 | 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE | DB07385 | |
0.3679 | Topotecan | DB01030 | |
0.3679 | 6-Hydroxypropylthymine | DB04139 | |
0.3660 | 6-(Dihydroxy-Isobutyl)-Thymine | DB02500 | |
0.3659 | Paliperidone | DB01267 | |
0.3603 | 3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol | DB02395 | |
0.3593 | 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE | DB07787 | |
0.3584 | 10-hydroxycamptothecin | DB12385 | |
0.3578 | Phenindamine | DB01619 | |
0.3541 | Ocaperidone | DB06229 | |
0.3541 | Ritanserin | DB12693 | |
0.3537 | Lurtotecan | DB12222 | |
0.3534 | Fimasartan | DB09279 |